In its second round of venture funding, CV Ingenuity raised $16 million.
The Palo Alto company makes a medical device — a balloon that releases a drug — used to treat vascular disease.
New Enterprise Associates led the round and put Ryan Drant and Justin Klein on the board of directors at CV Ingenuity.
No comments:
Post a Comment